drugset / Trial / NCT05921448

Vaccine Pandemic Preparedness Through Airway Immunology Characterization

NCT05921448

Phase 0 Active not recruiting 60 enrolled Copenhagen Respiratory Research The Novo Nordic Foundation · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The study aims to compare the effectiveness of live attenuated influenza vaccines (LAIV) and intramuscular-inactivated vaccines (IIV) in healthy individuals aged 18-49. It will investigate cellular and humoral responses, identify immunological markers for targeted vaccine improvement, and establish a collaborative platform for accelerated immunological and clinical vaccine research.

Timeline

Start
2025-05-19
Primary completion
2026-07-27
Completion
2026-07-27

Drugs

EvaluationDrugModalityDoseRoute
Subject FluMist Vaccine 0.2 ml Intranasal
Subject Vaxigripetra Vaccine 0.5 ml Intramuscular

Indications